Related Experiment Video
Updated: Apr 4, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Systemic vasculitis: one year in review 2026
Chiara Marvisi1, Paolo Delvino2, Federica Di Cianni3
1Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia; and Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy. chiara.marvisi@gmail.com.
None:
Systemic vasculitides are rare, heterogeneous inflammatory diseases associated with significant morbidity due to vascular and end-organ damage.In 2025, major advances have refined pathogenic insights and therapeutic strategies across large-vessel vasculitis (LVV), ANCA-associated vasculitis (AAV), single-organ vasculitis, and cryoglobulinemic vasculitis (CV). Multi-omics and spatial transcriptomic approaches, imaging, and serological biomarkers are informing prognosis and management.Glucocorticoid minimisation remains a unifying therapeutic goal. Targeted therapies such as JAK inhibitors, avacopan and anti-IL-5/IL-5R agents have demonstrated efficacy and steroid-sparing effects in both trials and real-world studies. Together, these advances mark a transition toward precision, phenotype-driven management in systemic vasculitis.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Nephrotic Syndrome I : Introduction
Endocarditis I: Introduction

